Jun 272017
 

Carl’s Jr. Underpays Employees

 

CITY OF LOS ANGELES SEEKS $1.45 MILLION IN RESTITUTION, PENALTIES FROM CARL’S Jr. RESTAURANTS FOR ALLEGEDLY FAILING TO PAY L.A. WORKERS MINIMUM WAGE

City Attorney Mike Feuer and City’s Office of Wage Standards Join to Protect Workers

 

City Attorney Mike Feuer and the City’s Office of Wage Standards announced that the City has taken action against Carl’s Jr. Restaurants LLC, demanding the company pay $1.45 million in restitution and penalties for repeatedly failing to pay dozens of workers at multiple Los Angeles locations the City’s minimum wage.

“L.A. law is clear: employees must be paid at least the minimum wage. Anything less is a slap in the face to workers struggling to make ends meet. This is a major corporation that should know the rules,” said Feuer. “Our offices will always aggressively stand up for workers to ensure they get the wages they’re owed, and all the protections and benefits the law demands.”

“The minimum wage is a legally established threshold below which employers may not venture to pay their workers,” said John Reamer, Inspector of Public Works and head of the Bureau of Contract Administration. “The minimum wage was established to ensure economic equity and opportunity, and the Office of Wage Standards will continue to partner with the City Attorney to regulate and enforce compliance with the law.”

Following a report from a Carl’s Jr. employee, L.A.’s Office of Wage Standards (OWS) (in the Bureau of Contract Administration) launched an investigation in coordination with the City Attorney’s Office. As a result of the investigation into the company’s financial records, it is alleged that Carl’s Jr. Restaurants LLC failed to pay 37 employees the Los Angeles minimum wage of $10.50 per hour from July 1, 2016 through December 31, 2016. In addition, the City cited the company for allegedly failing to post the notice of the current minimum wage rate, sick time benefits and employee rights required under the City’s Minimum Wage Ordinance at two Los Angeles locations.

The City is demanding the company pay $910,010 in penalties to the 37 employees identified by OWS investigators no later than July 24, 2017. (The funds are to be delivered to and distributed by the OWS to impacted employees.) The City is seeking an additional $541,423 in penalties and fines for allegedly: violating the City’s minimum wage law, failing to post the required notice and failing to provide investigators access to interview employees at two locations.

Failure to make payments could result in a civil action. Additionally, a lien could be placed against any property owned or operated by an employer who fails to pay wages, penalties, and administrative fines calculated by the City Attorney’s Office.

Deputy City Attorney Alexander Freedman and Dania Minassian are assigned to the matter.

 

Comment?

Name
Email
Comment Title
Rating
Comment Content

 

 

Jun 132017
 

LA City Attorney Cracks A Case of Counterfeit Pharmaceuticals

 

CITY ATTORNEY FEUER DETAILS LATEST CRACKDOWN, WARNS PUBLIC ABOUT DANGERS OF ILLEGAL SALE OF MIS-LABELED, COUNTERFEIT PHARMACEUTICAL DRUGS

 

City Attorney Mike Feuer today detailed his office’s latest efforts to crack down on local merchants known to illegally sell counterfeit or mis-labeled pharmaceutical drugs as well as warn the public about their serious health and safety dangers.

“My office and our law enforcement partners will fight to protect consumers from the health and safety hazards posed by illegal pharmaceuticals,” said Los Angeles City Attorney Mike Feuer. “We’ll continue to aggressively prosecute people who dispense these drugs that endanger communities throughout Los Angeles.”

A civil law enforcement action was filed against Narcisco and Johana Gamez alleging illegal dispensing and furnishing of dangerous prescription drugs without a license, possession of mis-branded pharmaceuticals and unlawful possession and sale of narcotics.

The defendants are father and daughter operators of Ducleria El Venado, a storefront selling miscellaneous items including candy, snacks, herbs, tea and piñatas located at 11653 N. Glenoaks Boulevard in Pacoima. During multiple undercover investigations by the Los Angeles County Sheriff Department and private investigators, defendants allegedly sold illegal, dangerous, mis-labeled and counterfeit pharmaceuticals. Neither defendant is licensed to sell pharmaceuticals nor is the business a pharmacy.

The complaint alleges that since at least 2014, the defendants possessed and sold counterfeit pharmaceuticals including the injectable anti-inflammatory drug Diprospan, various misbranded pharmaceuticals which are prohibited from distribution in the United States, and narcotics which are illegal without a prescription. Investigators conducted multiple undercover operations at the business to purchase combinations of counterfeit and unlicensed pharmaceuticals from the defendants. Subsequent search warrants found stockpiles of misbranded and haphazardly stored drugs at the business.

The lawsuit calls for the permanent termination of the lease at the business and seeks an injunction prohibiting the defendants from continuing to illegally sell any pharmaceutical products and other unlawful business practices as well as operating any business elated to the manufacture, sale, storage and possession of commonly counterfeited goods. The defendants could also face up to $2,500 in penalties for each violation.

The City Attorney’s lawsuit is part of ongoing operations coordinated through the Health Authority Law Enforcement Taskforce (HALT) including the Los Angeles Sheriff’s Department, LAPD, and the LA County Dept. of Health Services. HALT operations target distributors and sellers of illegal pharmaceuticals at swap meets and small local stores. Products seized by law enforcement include antibiotics and antibiotic powders, steroid ointments, diet pills, diuretics, pharmaceutical placebos, liquid oils, creams and silicone products that may be used for body enhancements–pharmaceuticals that require prescriptions or cannot lawfully be sold in the United States. These products include drugs bearing non-English labels, drugs without lot numbers, warnings or expiration dates, and drugs not in original packaging.

Deputy City Attorney Kevin Gilligan, director of the City Attorney’s Anti-Counterfeit Enforcement Program, is handling the litigation.

 

 

Comment?

Name
Email
Comment Title
Rating
Comment Content